Skip to main content
SpringerLink
Log in

Evidence in Guidelines for Treatment of Coronary Artery Disease

  • Chapter
  • First Online:
Coronary Artery Disease: Therapeutics and Drug Discovery

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1177))

Abstract

In this chapter, we focus on evidences in current guidelines for treatment of coronary artery disease (CAD). In Part 1, diet and lifestyle management is discussed, which plays an important role in CAD risk control, including forming healthy dietary pattern, maintaining proper body weight, physical exercise, smoking cessation, and so on. Part 2 elaborated on revascularization strategies and medical treatments in patients presenting with acute coronary syndrome (ACS), including specific AHA and ESC guidelines on ST elevation myocardial infarction (STEMI) and non-ST elevation ACS (NSTE-ACS). Part 3 discussed chronic stable coronary artery disease (SCAD), the treatment objective of which is a combination of both symptomatic and prognostic improvement. Yet many of the recommendations for SCAD are expert-based rather than evidence-based. Initial medical treatment is safe and beneficial for most patients. While cumulating studies have focused on optimizing pharmacological therapy (referring to nitrates, beta-blockers, calcium channel blockers, antiplatelet agents, ACEI/ARB, statins, etc.), education, habitual modification, and social support matters a lot for reducing cardiac morbidity and mortality. Patients with moderate-to-severe symptoms and complex lesions should be considered for revascularization. But practical management of revascularization shall take individual characteristics, preference, and compliance into consideration as well.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • ACCORD Study Group (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362(17): 1575

    Google Scholar 

  • American College of Emergency P, Society for Cardiovascular A, Interventions et al (2013) ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61(4): e78–140

    Google Scholar 

  • American Heart Association Nutrition C, Lichtenstein AH, Appel LJ, et al (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114(1): 82–96

    Google Scholar 

  • Amsterdam EA, Wenger NK, Brindis RG et al (2014) 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64(24):e139–e228

    Article  PubMed  Google Scholar 

  • Ardissino D et al (1995) Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 25(7):1516–1521

    Article  CAS  PubMed  Google Scholar 

  • Armaganijan LV, Alexander KP, Huang Z et al (2016) Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Am Heart J 178:176–184

    Article  CAS  PubMed  Google Scholar 

  • Auffret V, Leurent G, Boulmier D et al (2016) Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry. Arch Cardiovasc Dis 109(12):696–707

    Article  PubMed  Google Scholar 

  • Baigent C et al (2010) Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 376(9753): 1670–1681

    Google Scholar 

  • Bavishi C, Panwar S, Messerli FH, Bangalore S (2015) Meta-analysis of comparison of the newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in patients with non-ST-elevation acute coronary syndrome. Am J Cardiol 116(5):809–817

    Article  CAS  PubMed  Google Scholar 

  • Berger JS, Brown DL, Becker RC (2008) Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med 121(1):43–49

    Article  CAS  PubMed  Google Scholar 

  • Bhupathiraju SN, Wedick NM, Pan A et al (2013) Quantity and variety in fruit and vegetable intake and risk of coronary heart disease. Am J Clin Nutr 98(6):1514–1523

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blumenthal JA et al (2003) Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 55(2):604

    Article  Google Scholar 

  • Brener S et al (2006) Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular. Am Heart J 152(6):1059–1063

    Article  CAS  PubMed  Google Scholar 

  • Burg MM, Benedetto MC, Soufer R (2003) Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med 65(4):508

    Article  PubMed  Google Scholar 

  • Camafort M et al (2011) Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA registry. Diabet Med 28(1): 73–80

    Google Scholar 

  • Chaitman BR et al (2004) Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Card 43(8): 1375–1382

    Google Scholar 

  • Chazov EI et al (2005) Trimetazidine in Angina Combination Therapy–the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study. Am J Ther 12(1):35

    Article  CAS  PubMed  Google Scholar 

  • Chen H et al (2013) Relationship of depression, stress and endothelial function in stable angina patients. Physiol Behav 118(4):152–158

    Article  CAS  PubMed  Google Scholar 

  • Chetboul V, Reynolds BS, Trehiou-Sechi E et al (2014) Cardiovascular effects of dietary salt intake in aged healthy cats: a 2-year prospective randomized, blinded, and controlled study. PLoS ONE 9(6):e97862

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chow CK et al (2010) Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 121(6):750

    Article  PubMed  Google Scholar 

  • Cohen DJ et al (2014) Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 130(14):1146–1157

    Article  CAS  PubMed  Google Scholar 

  • Critchley JA, Capewell S (2003) Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA J Am Med Assoc 290(1):86–97

    Article  Google Scholar 

  • Dalmeijer GW, Struijk EA, van der Schouw YT et al (2013) Dairy intake and coronary heart disease or stroke—a population-based cohort study. Int J Cardiol 167(3):925–929

    Article  PubMed  Google Scholar 

  • De Bruyne B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991–1001

    Article  PubMed  CAS  Google Scholar 

  • Diercks DB et al (2006) The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the American College of Cardiology/American Heart Association guidelines quality improvement initiative. Am Heart J 152(1):140–148

    Article  PubMed  Google Scholar 

  • Elgendy IY, Huo T, Bhatt DL, Bavry AA (2015) Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? Meta-analysis of randomized trials. Circ Cardiovasc Interv 8(7):e002258

    Article  PubMed  Google Scholar 

  • Farag M, Gorog DA, Prasad A, Srinivasan M (2015) Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes. Open Heart 2(1):e000258

    Article  PubMed  PubMed Central  Google Scholar 

  • Farkouh ME et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367(25):2375–2384

    Article  CAS  PubMed  Google Scholar 

  • Fihn SD et al (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the A. Circulation 60(24):2564–2603

    Google Scholar 

  • Fox KM et al (1996) The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group. Eur Heart J 17(1): 96–103

    Google Scholar 

  • Fox KM (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362(9386):782–788

    Article  CAS  PubMed  Google Scholar 

  • Fox K et al (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372(9641):807–816

    Article  CAS  PubMed  Google Scholar 

  • Frasuresmith N, Lespérance F (2003) Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 60(6):627–636

    Article  Google Scholar 

  • Frasuresmith N, Lespérance F (2008) Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 65(1):62

    Article  CAS  Google Scholar 

  • Frasuresmith N, Lespérance F, Talajic M (1993) Depression following myocardial infarction. Impact on 6-month survival. JAMA J Am Med Assoc 270(15): 1819

    Google Scholar 

  • Gan Y, Tong X, Li L et al (2015) Consumption of fruit and vegetable and risk of coronary heart disease: a meta-analysis of prospective cohort studies. Int J Cardiol 183:129–137

    Article  PubMed  Google Scholar 

  • Geisler T, Droppa M, Gawaz M et al (2016) Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial. Catheter Cardiovasc Interv 88(2):174–181

    Article  PubMed  Google Scholar 

  • Glover M, Zuber AM, O’Shaughnessy KM (2011) Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT. Cardiovasc Ther 29(1):68–76

    Article  CAS  PubMed  Google Scholar 

  • Graham DJ et al (2014) Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study. Pharmacoepidemiol Drug Saf 23(11):1205–1212

    Article  CAS  PubMed  Google Scholar 

  • Grandi SM, Shimony A, Eisenberg MJ (2013) Bupropion for smoking cessation in patients hospitalized with cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Can J Cardiol 29(12):1704–1711

    Article  PubMed  Google Scholar 

  • Guarini G et al (2016) Pharmacological agents targeting myocardial metabolism for the management of chronic stable angina: an update. Cardiovasc Drugs Ther 30(4):379–391

    Article  CAS  PubMed  Google Scholar 

  • Gunton J, Hartshorne T, Langrish J, Chuang A, Chew D (2016) P2Y12 inhibitor pre-treatment in non-ST-elevation acute coronary syndrome: a decision-analytic model. J Clin Med 5(8)

    Google Scholar 

  • Gurfinkel EP et al (2004) Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 25(1):25–31

    Article  PubMed  Google Scholar 

  • Harris KA, Kris-Etherton PM (2010) Effects of whole grains on coronary heart disease risk. Curr Atheroscler Rep 12(6):368–376

    Article  CAS  PubMed  Google Scholar 

  • Harris JR, Hale GM, Dasari TW, Schwier NC (2016) Pharmacotherapy of vasospastic angina. J Cardiovasc Pharmacol Ther 21(5):439–451

    Article  CAS  PubMed  Google Scholar 

  • Hermanson B et al (1988) Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 319(21): 1365

    Google Scholar 

  • Hueb W et al (2004) The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 43(10):1743–1751

    Article  PubMed  Google Scholar 

  • Hueb W et al (2007) Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115(9):1082–1089

    Article  PubMed  Google Scholar 

  • Hueb W et al (2010) Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 122(10):949–957

    Article  PubMed  Google Scholar 

  • Jang JS, Jin HY, Seo JS et al (2015) Meta-analysis of multivessel versus culprit-only percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome and multivessel coronary disease. Am J Cardiol 115(8):1027–1032

    Article  PubMed  Google Scholar 

  • Janssen V et al (2012) Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol 20(4):620–640

    Article  PubMed  Google Scholar 

  • Jolly SS, Cairns JA, Yusuf S et al (2016) Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet 387(10014):127–135

    Article  PubMed  Google Scholar 

  • Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Hartman N, McGovern PG (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. NEJM N Engl J Med 335(24): 1792

    Google Scholar 

  • Julius S et al (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363(9426):2022–2031

    Article  CAS  PubMed  Google Scholar 

  • Juul-Moller S et al (1992) Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 340(8833): 1421–1425

    Google Scholar 

  • Kolh P et al (2014) ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of. Eur J Cardio-Thoracic Surg 72(4): 1253–1379

    Google Scholar 

  • Kosiborod M et al (2013) Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol 61(20):2038–2045

    Article  CAS  PubMed  Google Scholar 

  • Krauss RM, Eckel RH, Howard B et al (2000) AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke 31(11):2751–2766

    Article  CAS  PubMed  Google Scholar 

  • Lamberts M et al (2014) Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation 129(15):1577–1585

    Article  CAS  PubMed  Google Scholar 

  • Lancet T (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348(9038):1329

    Article  Google Scholar 

  • Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53(21):1925–1932

    Article  PubMed  Google Scholar 

  • Lemesle G et al (2016) Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the CORONOR Study). Cardiology 134(1):11–18

    Article  CAS  PubMed  Google Scholar 

  • Lemesle G et al (2017) Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study). J Cardiol 69(3):542–547

    Article  PubMed  Google Scholar 

  • Li F, Li Y, Wang L (2013) The impact of anxiety and depression on prognosis in patients with coronary heart disease after percutaneous coronary intervention. China J Heal Psychol

    Google Scholar 

  • Lima EG et al (2013) Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. Am Heart J 166(2):250–257

    Article  PubMed  Google Scholar 

  • Lindholm LH et al (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359(9311):1004–1010

    Article  CAS  PubMed  Google Scholar 

  • Lu Y, Hajifathalian K et al. (2014) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 383(9921): 970–983. Global burden of metabolic risk factors for chronic diseases C

    Google Scholar 

  • McGuire S, U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans (2010). 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011. Adv Nutr 2(3): 293–294 (2011)

    Google Scholar 

  • Mcrobbie H, Hajek P (2001) Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction 96(11):1547–1551

    Article  CAS  PubMed  Google Scholar 

  • Melloni C, Newby LK (2008) Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study. Expert Rev Cardiovasc Ther 6(1):9–16

    Article  CAS  PubMed  Google Scholar 

  • Members ATF et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569–2619

    Article  CAS  Google Scholar 

  • Mohammad MA, Andell P, Koul S et al (2016) Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction. Platelets: 1–3

    Google Scholar 

  • Nagumo S, Wakabayashi K, Tsujiuchi M et al (2016) Clinical impact of undersized- versus oversized-stenting approaches in ST-elevation myocardial infarction. Cardiovasc Revascularization Med Incl Mol Interv 17(6):362–368

    Article  Google Scholar 

  • Noh Y, Lee J, Shin S et al (2016) Antiplatelet therapy of cilostazol or sarpogrelate with aspirin and clopidogrel after percutaneous coronary intervention: a retrospective cohort study using the Korean National Health Insurance Claim Database. PLoS ONE 11(3):e0150475

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Oguzkurt L, Ozkan U, Gumus B, Coskun I, Koca N, Gulcan O (2010) Percutaneous aspiration thrombectomy in the treatment of lower extremity thromboembolic occlusions. Diagn Interv Radiol 16(1):79–83

    PubMed  Google Scholar 

  • Peiyuan H, Jingang Y, Haiyan X et al (2016) The comparison of the outcomes between primary PCI, fibrinolysis, and no reperfusion in patients >/= 75 years old with ST-segment elevation myocardial infarction: results from the Chinese Acute Myocardial Infarction (CAMI) registry. PLoS ONE 11(11):e0165672

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pepine CJ et al (1994) Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 90(2): 762–768

    Google Scholar 

  • Pepine CJ et al (2003) A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA J Am Med Assoc 13(2): 19–20

    Google Scholar 

  • Pfisterer M (2004) Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 110(10):1213–1218

    Article  PubMed  Google Scholar 

  • Prati F, Romagnoli E, Limbruno U et al (2015) Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: the COCTAIL II trial. Am Heart J 170(6):1116–1123

    Article  CAS  PubMed  Google Scholar 

  • Rehnqvist N et al (1995) Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm. Cardiologia 40(40): 301

    Google Scholar 

  • Rigotti NA et al (2010) Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation 121(2):221–229

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315

    Article  CAS  PubMed  Google Scholar 

  • Rosendorff C et al (2015) Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Am J Med 131(19):e435

    Google Scholar 

  • Ross Terres JA, Lozano-Ortega G, Kendall R, Sculpher MJ (2015) Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5). BMC Cardiovasc Disord 15:180

    Article  PubMed  CAS  Google Scholar 

  • Shaw LJ et al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation 117(10):1283–1291

    Article  PubMed  Google Scholar 

  • Shehata M, Fayez G, Nassar A (2015) Intensive Statin Therapy in NSTE-ACS patients undergoing PCI: clinical and biochemical effects. Tex Heart Inst J 42(6):528–536

    Article  PubMed  PubMed Central  Google Scholar 

  • Shibeshi WA, Young-Xu Y, Blatt CM (2007) Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol 49(20):2021

    Article  PubMed  Google Scholar 

  • Shu DF et al (2012) Long-term beta blockers for stable angina: systematic review and meta-analysis. Eur J Prev Cardiol 19(3):330–341

    Article  Google Scholar 

  • Squizzato A et al (2011) Clopidogrel plus Aspirin versus Aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev (1): CD005158

    Google Scholar 

  • Steg PG, Bhatt DL, Hamm CW et al (2013) Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data. Lancet 382(9909):1981–1992

    Article  CAS  PubMed  Google Scholar 

  • Stone PH et al (2006) Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol 48(3):566–575

    Article  CAS  PubMed  Google Scholar 

  • Szwed H et al (2001) Combination treatment in stable effort angina using trimetazidine and metoprolol. Results of a randomized, double-blind, multicentre study (TRIMPOL II). 22(24): 2267–2274

    Google Scholar 

  • Tang G, Wang D, Long J, Yang F, Si L (2015) Meta-analysis of the association between whole grain intake and coronary heart disease risk. Am J Cardiol 115(5):625–629

    Article  PubMed  Google Scholar 

  • Task Force on the management of STseamiotESoC, Steg PG, James SK et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20): 2569–2619

    Google Scholar 

  • Trikalinos TA et al (2009) Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet 373(9667):911

    Article  PubMed  PubMed Central  Google Scholar 

  • Udell JA et al (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310(16):1711

    Article  CAS  PubMed  Google Scholar 

  • Vitale C et al (2012) Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina–the VASCO-angina study. Int J Cardiol 168(2):1078–1081

    Article  PubMed  Google Scholar 

  • Von AT (1995) Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), A multicenter trial comparing bisoprolol and nifedipine. The TIBBS investigators. J Am Coll Cardiol 25(1): 231–238

    Google Scholar 

  • Whooley MA et al (2011) Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA J Am Med Assoc 300(20):2379–2388

    Article  Google Scholar 

  • Worm N, Belz GG, Stein-Hammer C (2013) Moderate wine consumption and prevention of coronary heart disease. Dtsch Med Wochenschr 138(51–52):2653–2657

    CAS  PubMed  Google Scholar 

  • Yusuf S et al (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342(3): 145–153. The Heart Outcomes Prevention Evaluation Study Investigators

    Google Scholar 

  • Yusuf S et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358(15):1547–1559

    Article  CAS  PubMed  Google Scholar 

  • Zhao XM, Gao CY, Chu YJ et al (2015) Fondaparinux vs. enoxaparin in patients with non-ST elevation acute coronary syndromes (NSTE-ACS) treated with percutaneous coronary intervention and tirofiban: an exploratory study in China. J Clin Pharm Ther

    Google Scholar 

  • Zong G, Gao A, Hu FB, Sun Q (2016) Whole grain intake and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. Circulation 133(24):2370–2380

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Sida Jia, Yue Liu & Jinqing Yuan

Authors
  1. Sida Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yue Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jinqing Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jinqing Yuan .

Editor information

Editors and Affiliations

  1. Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Miao Wang

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jia, S., Liu, Y., Yuan, J. (2020). Evidence in Guidelines for Treatment of Coronary Artery Disease. In: Wang, M. (eds) Coronary Artery Disease: Therapeutics and Drug Discovery. Advances in Experimental Medicine and Biology, vol 1177. Springer, Singapore. https://doi.org/10.1007/978-981-15-2517-9_2

Download citation

Publish with us

Policies and ethics

Search

Navigation